Evidence map›Paper›PMID 36272774›Full record

Observational studySurgery2022

Telemedicine and intraductal papillary mucinous neoplasms: Analysis of a new follow-up strategy during COVID-19 outbreak.

J Farguell, V Holguin, C González, I Gil, C Arrocha, F Landi, E Vaquero, A Gines, C Fillat, F Ausania

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

J FarguellDepartment of Surgery, Hospital Clinic, University of Barcelona, Spain. Electronic address: jfarguell@clinic.cat.
V HolguinDepartment of Surgery, Hospital Clinic, University of Barcelona, Spain.
C GonzálezDepartment of Surgery, Hospital Clinic, University of Barcelona, Spain. Electronic address: https://twitter.com/carol_gonzaleza.
I GilDepartment of Surgery, Hospital Clinic, University of Barcelona, Spain. Electronic address: https://twitter.com/IgnacioGil__.
C ArrochaDepartment of Surgery, Hospital Clinic, University of Barcelona, Spain.
F LandiDepartment of Surgery, Hospital Clinic, University of Barcelona, Spain. Electronic address: https://twitter.com/FilippoLandi_.
E VaqueroDepartment of Gastroenterology, Hospital Clinic, University of Barcelona, Spain.
A GinesDepartment of Gastroenterology, Hospital Clinic, University of Barcelona, Spain.
C FillatGene Therapy and Cancer, IDIBAPS, Barcelona, Spain. Electronic address: https://twitter.com/cfillat.
F AusaniaDepartment of Surgery, Hospital Clinic, University of Barcelona, Spain; Gene Therapy and Cancer, IDIBAPS, Barcelona, Spain. Electronic address: https://twitter.com/fabio_ausania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Coronavirus pandemic outbreak in 2019 and the saturation of healthcare system led to an increased use of digital tools for surveillance. In this study we described our experience using telemedicine to follow-up on patients with intraductal papillary mucinous neoplasms during the COVID-19 era and analyze those factors associated to patients' satisfaction.

methodsThis 1-year retrospective observational study enrolled patients with intraductal papillary mucinous neoplasms followed-up by telemedicine during COVID-19 outbreak. Patients with high-risk features needing on-site physical examination or declining remote follow-up were excluded. A 13-question survey was conducted; demographic, geographic, and employment information was collected. Univariate and multivariate analyses were performed to evaluate those factors associated to patients' satisfaction.

resultsOut of 287, a total of 177 patients with intraductal papillary mucinous neoplasms were included: the mean age was 69 (44-87) years and the male/female ratio was 0.78. A total of 80 (45.2%) patients had previously experienced abdominal pain. Most patients (85.3%) were satisfied with telemedicine: at univariate analysis, age ≥70 years (P = .007), retirement (P = .001), and absence of previous abdominal pain (P = .05) were significantly associated with patient satisfaction. At multivariate analysis, the absence of previous abdominal pain was the only factor independently associated with patient satisfaction (odds ratio 5.964, 95% confidence interval 2.21-16.11, P < .001).

conclusionTelemedicine allows a new follow-up strategy that can be used in selected patients with intraductal papillary mucinous neoplasms. The absence of previous abdominal pain is associated with patient satisfaction during follow-up. Further studies are needed to evaluate safety of remote follow-up in patients with intraductal papillary mucinous neoplasms.

Indexed as

Adenocarcinoma, MucinousCarcinoma, Pancreatic DuctalCarcinoma, PapillaryCOVID-19Pancreatic NeoplasmsTelemedicineAbdominal PainAgedDisease OutbreaksFemaleFollow-Up StudiesHumansMale

Identifiers

PMID36272774
PMCPMC9468315

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.